The purpose of the study is to monitor the general functional changes among patients with schizophrenia, treated with atypical antipsychotics dosed once daily for a period of 6 months.The primary study objective is to compare general functioning of patients with schizophrenia treated with Seroquel SR between baseline and the last study visit. The secondary study objectives are to compare general functioning of patients with schizophrenia treated with other atypical antipsychotic medicinal products administered once daily between baseline and the last study visit, monitoring of other indicators of clinical improvement, evaluation of patient compliance and assessment of occurrence of adverse effects
Study Type
OBSERVATIONAL
Enrollment
106
Research Site
Begunje na Gorenjskem, Slovenia
Research Site
Brezovica pri Ljubljani, Slovenia
Research Site
Brežice, Slovenia
Research Site
Idrija, Slovenia
Research Site
Koper, Slovenia
Research Site
Ljubljana, Slovenia
Research Site
Maribor, Slovenia
Research Site
Nova Gorica, Slovenia
Research Site
Novo Mesto, Slovenia
Research Site
Ormož, Slovenia
...and 4 more locations
To compare improvement in global assessment of functioning (using the GAF scale) between the baseline and the final study visit in the Seroquel SR-treated group.
Time frame: three times: 0, 12 and 24 weeks after inclusion
To assess improvement in global assessment of functioning (using the GAF scale) between the baseline and the final study visit in the group of patients treated with other atypical antipsychotics
Time frame: three times: 0, 12 and 24 weeks after inclusion
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.